Since diabetes, linked itself to dysregulation of GSK3β activity, is associated in late-life with an increased risk of dementia, epidemiological and experimental studies are summarized in this issue in order to understand the effects of diabetes mellitus on tau pathogenesis. The gene discussed is MAPT; the disease is diabetes mellitus.